ss ss ss ss ss
100% correct detailed answers
ss ss ss ss
(verified answers) already passed
ss ss ss ss
and rated a+ ss ss ss
Antipsychotics Table Assignments
ss ss .
, Drug ssname Indication Half-life Notable ssside sseffects ss(associate ssto sspathway ssor
Target sssymptoms: ssstate ssif sspositive ssor ssnegative ss(T1/2), ssNT)
sseffectsPotency ss(if ssnoted. ssreceptor ssoccupancy ssif smetabolism
ssnoted ss) ssNeurotransmitter(s) ssaffected ss(CYP ss450
enzyme)
Typical ssantipsychotics ss(conventional)
Haloperidol Blocks ssdopamine ss2 ssreceptors, ssreducing sspositive Decanoate Acute ssblockade ssof ssdopamine ss2 ssreceptors
sssymptoms ssof sspsychosis ssand sspossibly sscombative, sshalf-life ssin ssthe s s triatum sscan sscause ssdrug-induced
ssexplosive, ssand sshyperactive ssbehaviors ssBlocks ssapproximatel ssparkinsonism,sdystonia, ssor ssakathisia
ssdopamines2 ssreceptors ssin ssthe ssnigrostriatal sspathway, ys3 ssweeks Chronic ssblockade ssof ssdopamine ss2 ssreceptors ssin
ssimproving ssticssand ssother sssymptoms ssin ssTourette’s ssOral sshalf-life ssthesstriatum sscan sscause sstardive ssdyskinesia
sssyndrome. ssapproximatel By ssblocking ssdopamine ss2 ssreceptors ssin ssthe
ys12–38 sshours sspituitary,sit sscan sscause sselevations ssin ssprolactin
By ssblocking ssdopamine ss2 ssreceptors
ssexcessively ssinsthe ssmesocortical ssand
ssmesolimbic ssdopamine sspathways, ssespecially
ssat sshigh ssdoses, ssit sscan sscause ssworsening ssof
ssnegative ssand sscognitive sssymptoms
ss(neuroleptic-induced ssdeficit sssyndrome).
Blocking ssalpha ss1 ssadrenergic ssreceptors sscan sscause
dizziness, sshypotension, ssand sssyncope
Thioridazine Blocks ssdopamine ss2 ssreceptors, ssreducing Metabolized Acute ssblockade ssof ssdopamine ss2 ssreceptors
sspositives
s ymptoms ssof sspsychosis ssby ssCYP450 ssin ssthe sstriatum sscan sscause ssdrug-induced
ss2D6 ssparkinsonism,sdystonia, ssor ssakathisia.
Chronic ssblockade ssof ssdopamine ss2 ssreceptors ssin
ssthesstriatum sscan sscause sstardive ssdyskinesia
By ssblocking ssdopamine ss2 ssreceptors ssin ssthe
sspituitary,sit sscan sscause sselevations ssin ssprolactin
By ssblocking ssdopamine ss2 ssreceptors
ssexcessively ssinsthe ssmesocortical ssand
ssmesolimbic ssdopamine sspathways, ssespecially
ssat sshigh ssdoses, ssit sscan sscause ssworsening ssof
ssnegative ssand sscognitive sssymptoms
ss(neuroleptic-induced ssdeficit sssyndrome)
Blocking ssmuscarinic sscholinergic ssreceptors sscan